KP Tissue Releases Third Quarter 2021 Financial Results
KPLP Q3 2021 Business and Financial Highlights • Revenue increased by $22.3 million or 6.0% to $391.4 million in Q3 2021 compared to $369.1 million in Q3 2020. • Adjusted EBITDA was $40.3 million in Q3 2021 compared to $46.2 million in Q3 2020, a decrease of 12.8%, and improved sequentially from $37.3 million in Q2 2021. • TAD Sherbrooke continues to run above the expected start-up curve. • Declared a quarterly dividend of $0.18 per share to be paid on January 17, 2022